Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroquinone 4% versus glucosamine 2% topical cream for melasma
IRCT20120215009014N399Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in melasma comparing Hydroquinone arm with Glucosamine arm (2 arms). Primary endpoint: Lesion size. Started Jul 2021; status: completed.
02
Drugs
hydroquinoneglucosamine sulphate
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20120215009014N399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N399.